Related Experiment Video
Updated: May 9, 2025

Author Spotlight: Tracing the Ferroptotic Signatures and Cell Death Dynamics in Medulloblastoma for Advanced Therapeutics
Published on: March 15, 2024
Oncogenic HNF4α inhibits ferroptotic cell death through activating SLC7A11 by recruiting p300/CBP in breast cancer
Zhuang Wang1, Sen Xu1, Jinxia Hu1
1Department of Biochemistry and Molecular Biology, Binzhou Medical University, YanTai, ShanDong 264003, PR China.
Abstract:
As an iron-dependent novel form of cell death caused by the accumulation of lipid peroxides, ferroptosis has been gradually recognized as a new cancer therapeutic target in recent years. Although the precise mechanisms underlying iron-induced cell death remain incompletely elucidated, this study identifies its distinctive role. A decrease in hepatocyte nuclear factor 4-alpha (HNF4α) activity could increase ferroptosis in breast cancer (BC) cells both in vitro and in vivo. Mechanistically, it was found that HNF4α binds directly to the promoter of SLC7A11, where it recruits the histone acetyltransferase p300/CBP to promote transcription of SLC7A11. Our study shows that HNF4α is crucial for ferroptosis in breast cancer, which may open up the possibility of developing a new therapeutic approach for advanced cancers resistant to chemotherapy.
Insights
Decreased hepatocyte nuclear factor 4-alpha (HNF4α) activity promotes ferroptosis, a novel cell death pathway, in breast cancer cells. This finding offers a potential new therapeutic strategy for chemotherapy-resistant advanced cancers.
Area of Science:
- Oncology
- Cell Biology
- Biochemistry
Background:
- Ferroptosis is an iron-dependent cell death characterized by lipid peroxide accumulation.
- Ferroptosis is an emerging therapeutic target for cancer treatment.
- The precise mechanisms regulating ferroptosis are not fully understood.
Purpose of the Study:
- To investigate the role of hepatocyte nuclear factor 4-alpha (HNF4α) in ferroptosis.
- To explore the potential of targeting HNF4α for breast cancer therapy.
Main Methods:
- In vitro and in vivo studies were conducted using breast cancer cell models.
- Investigated the binding of HNF4α to the SLC7A11 promoter.
- Assessed the recruitment of p300/CBP by HNF4α.
Main Results:
- Reduced HNF4α activity significantly increased ferroptosis in breast cancer cells.
- HNF4α directly binds to the SLC7A11 promoter.
- HNF4α recruits p300/CBP to enhance SLC7A11 transcription.
Conclusions:
- HNF4α plays a critical role in regulating ferroptosis in breast cancer.
- Targeting HNF4α could represent a novel therapeutic strategy for advanced, chemotherapy-resistant breast cancers.
Related Concept Videos
Necrosis
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
Abnormal Proliferation
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...

